Expiration date: 01/2021
Detail info about the product:
Packing: bottle of 10 ml
1.1. Phosprenyl is a product of pine - needles' polyprenol phosphorylation, composed mainly of a disodium salt of polyprenyl phosphate.
1.2. The drug is a colorless or yellowish, transparent or mildly opalescent solution
without any mechanical admixtures.
1.3. The drug is usually produced in 10 ml vials made of neutral glass.
1.4. The drug should be kept in a dark place without freezing. Best when used up to 12 months since the date of production.
2.1. Phosprenyl is active against viruses of canine distemper, parvoviruses, adenoviruses, coronaviruses and many other animal viruses.
2.2. Phosprenyl is shown to stimulate innate immunity, to possess anti - inflammatory, hepatoprotective, and detoxifying activities.
3.1. Phosprenyl is used as a preventive or therapeutical medication against viral infections of cats, dogs (feline panleukopenia, infectious peritonitis and viral rhinotracheitis; canine distemper, canine adenovirosis and viral hepatitis), calves (herpesviral rhinotracheitis, viral diarrhea), piglets (viral enteritis caused by coronaviruses or parvoviruses).
3.2. For treatment of the dogs the singular recommended Phosprenyl dose for i.m. injection is 0.1 - 0.2 ml per 1 kg. For treatment of the cats the singular recommended Phosprenyl dose for i.m. injection is 0.2 - 0.3 ml per 1 kg. For treatment of calves and piglets recommended Phosprenyl dose for i.m. injection is 0.1 - 0.2 ml per 1 kg. For treatment of viral diseases with grave or aggravating course viral diseases the singular dose for i.m. injection should be doubled. The animals may also be treated per os. In such cases the therapeutic dose should also be enhanced 2 - fold.
3.3. When treating grave and aggravating viral diseases, it is recommended to administer the drug in combination with antibiotics, anti - histamine drugs, Gamavite, and conventional means of symptomatic therapy.
3.4. In preventive purpose (following contacts with ill animals, before exhibitions, or before prolonged voyages) Phosprenyl should be administered at a singular dose 2 or 3 days in a row.
4.Containdications and adverse effects
4.1. The drug is practically non - toxic, but a temporary rise in a body temperature (1 - 1.5 oC), changes in a rhythm and strength of a heartbeat, and languidness may be sometimes observed 1 - 2 days following beginning of the treatment. In case of a high individual susceptibility the heart - supporting drugs (such as camphor or sulfocamphocaine) should be used.